168 related articles for article (PubMed ID: 31691579)
1. A randomized controlled clinical trial of a hypothermically stored amniotic membrane for use in diabetic foot ulcers.
Serena TE; Yaakov R; Moore S; Cole W; Coe S; Snyder R; Patel K; Doner B; Kasper MA; Hamil R; Wendling S; Sabolinski ML
J Comp Eff Res; 2020 Jan; 9(1):23-34. PubMed ID: 31691579
[No Abstract] [Full Text] [Related]
2. Use of hypothermically stored amniotic membrane on diabetic foot ulcers: a multicentre retrospective case series.
Sanchez A; Hartstein A; Ashry H; Raza M
J Wound Care; 2024 Mar; 33(Sup3):S16-S23. PubMed ID: 38457306
[TBL] [Abstract][Full Text] [Related]
3. In vitro assessment of a novel, hypothermically stored amniotic membrane for use in a chronic wound environment.
McQuilling JP; Vines JB; Mowry KC
Int Wound J; 2017 Dec; 14(6):993-1005. PubMed ID: 28370981
[TBL] [Abstract][Full Text] [Related]
4. Use of a dual-layer amniotic membrane in the treatment of diabetic foot ulcers: an observational study.
Sledge I; Maislin D; Bernarducci D; Snyder R; Serena TE
J Wound Care; 2020 Sep; 29(Sup9):S8-S12. PubMed ID: 32924804
[TBL] [Abstract][Full Text] [Related]
5. Use of an aseptically processed, dehydrated human amnion and chorion membrane improves likelihood and rate of healing in chronic diabetic foot ulcers: A prospective, randomised, multi-centre clinical trial in 80 patients.
DiDomenico LA; Orgill DP; Galiano RD; Serena TE; Carter MJ; Kaufman JP; Young NJ; Jacobs AM; Zelen CM
Int Wound J; 2018 Dec; 15(6):950-957. PubMed ID: 30019528
[TBL] [Abstract][Full Text] [Related]
6. A prospective clinical trial evaluating changes in the wound microenvironment in patients with chronic venous leg ulcers treated with a hypothermically stored amniotic membrane.
McQuilling JP; Carter MJ; Fulton JA; Patel K; Doner B; Serena TE; Mowry KC
Int Wound J; 2022 Jan; 19(1):144-155. PubMed ID: 33955178
[TBL] [Abstract][Full Text] [Related]
7. A prospective, randomised, controlled, multicentre clinical trial examining healing rates, safety and cost to closure of an acellular reticular allogenic human dermis versus standard of care in the treatment of chronic diabetic foot ulcers.
Zelen CM; Orgill DP; Serena T; Galiano R; Carter MJ; DiDomenico LA; Keller J; Kaufman J; Li WW
Int Wound J; 2017 Apr; 14(2):307-315. PubMed ID: 27073000
[TBL] [Abstract][Full Text] [Related]
8. A Prospective, Randomized, Multicenter, Controlled Evaluation of the Use of Dehydrated Amniotic Membrane Allograft Compared to Standard of Care for the Closure of Chronic Diabetic Foot Ulcer.
Snyder RJ; Shimozaki K; Tallis A; Kerzner M; Reyzelman A; Lintzeris D; Bell D; Rutan RL; Rosenblum B
Wounds; 2016 Mar; 28(3):70-7. PubMed ID: 26978860
[TBL] [Abstract][Full Text] [Related]
9. The Comparative Effectiveness of a Human Fibroblast Dermal Substitute versus a Dehydrated Human Amnion/Chorion Membrane Allograft for the Treatment of Diabetic Foot Ulcers in a Real-world Setting.
Kraus I; Sabolinski ML; Skornicki M; Parsons NB
Wounds; 2017 May; 29(5):125-132. PubMed ID: 28570252
[TBL] [Abstract][Full Text] [Related]
10. Treatment of diabetic foot ulcers with dehydrated amniotic membrane allograft: a prospective case series.
Abdo RJ
J Wound Care; 2016 Jul; 25(Sup7):S4-S9. PubMed ID: 29027851
[TBL] [Abstract][Full Text] [Related]
11. A Retrospective Case Series of a Dehydrated Amniotic Membrane Allograft for Treatment of Unresolved Diabetic Foot Ulcers.
Rosenblum BI
J Am Podiatr Med Assoc; 2016 Sep; 106(5):328-337. PubMed ID: 27439322
[TBL] [Abstract][Full Text] [Related]
12. A single-centre, retrospective study of cryopreserved umbilical cord/amniotic membrane tissue for the treatment of diabetic foot ulcers.
Raphael A
J Wound Care; 2016 Jul; 25(Sup7):S10-S17. PubMed ID: 29027852
[TBL] [Abstract][Full Text] [Related]
13. A Multinational, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Trial to Evaluate the Efficacy of Cyclical Topical Wound Oxygen (TWO2) Therapy in the Treatment of Chronic Diabetic Foot Ulcers: The TWO2 Study.
Frykberg RG; Franks PJ; Edmonds M; Brantley JN; Téot L; Wild T; Garoufalis MG; Lee AM; Thompson JA; Reach G; Dove CR; Lachgar K; Grotemeyer D; Renton SC;
Diabetes Care; 2020 Mar; 43(3):616-624. PubMed ID: 31619393
[TBL] [Abstract][Full Text] [Related]
14. Management of post-Mohs surgical wounds with a hypothermically stored amniotic membrane: a case series.
Kapp D; Pfendler L
J Wound Care; 2024 May; 33(Sup5):S22-S27. PubMed ID: 38683816
[TBL] [Abstract][Full Text] [Related]
15. Comparative effectiveness of a bioengineered living cellular construct vs. a dehydrated human amniotic membrane allograft for the treatment of diabetic foot ulcers in a real world setting.
Kirsner RS; Sabolinski ML; Parsons NB; Skornicki M; Marston WA
Wound Repair Regen; 2015 Sep; 23(5):737-44. PubMed ID: 26100572
[TBL] [Abstract][Full Text] [Related]
16. Cryopreserved amniotic membrane in the treatment of diabetic foot ulcers: a case series.
Valiente MR; Nicolás FJ; García-Hernández AM; Fuente Mora C; Blanquer M; Alcaraz PJ; Almansa S; Merino GR; Lucas MDL; Algueró MC; Insausti CL; Piñero A; Moraleda JM; Castellanos G
J Wound Care; 2018 Dec; 27(12):806-815. PubMed ID: 30557111
[TBL] [Abstract][Full Text] [Related]
17. Comparative effectiveness of a human fibroblast-derived dermal substitute and a viable cryopreserved placental membrane for the treatment of diabetic foot ulcers.
Sabolinski ML; Capotorto JV
J Comp Eff Res; 2019 Oct; 8(14):1229-1238. PubMed ID: 31407588
[No Abstract] [Full Text] [Related]
18. Treatment of chronic diabetic lower extremity ulcers with advanced therapies: a prospective, randomised, controlled, multi-centre comparative study examining clinical efficacy and cost.
Zelen CM; Serena TE; Gould L; Le L; Carter MJ; Keller J; Li WW
Int Wound J; 2016 Apr; 13(2):272-82. PubMed ID: 26695998
[TBL] [Abstract][Full Text] [Related]
19. A purified reconstituted bilayer matrix shows improved outcomes in treatment of non-healing diabetic foot ulcers when compared to the standard of care: Final results and analysis of a prospective, randomized, controlled, multi-centre clinical trial.
Armstrong DG; Orgill DP; Galiano RD; Glat PM; Kaufman JP; Carter MJ; DiDomenico LA; Zelen CM
Int Wound J; 2024 Apr; 21(4):e14882. PubMed ID: 38606794
[TBL] [Abstract][Full Text] [Related]
20. A prospective, randomised, controlled, multi-centre comparative effectiveness study of healing using dehydrated human amnion/chorion membrane allograft, bioengineered skin substitute or standard of care for treatment of chronic lower extremity diabetic ulcers.
Zelen CM; Gould L; Serena TE; Carter MJ; Keller J; Li WW
Int Wound J; 2015 Dec; 12(6):724-32. PubMed ID: 25424146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
